NIAID Banner Logo Image


1. 61116 HIV-LS-377; WOS-HI-6/15/2007

Cd4(+) T Cell Targeting of Human Immunodeficiency Virus Type 1 (Hiv-1) Peptide Sequences Present in Vivo During Chronic, Progressive Hiv-1 Disease

Boritz, E. et al.

Virology 2007. 361(1): 34-44


2. 61117 HIV-LS-377; SCIFINDER-HIV-6/18/2007

A new strategy to inhibit the excision reaction catalysed by HIV-1 reverse transcriptase: compounds that compete with the template-primer

Cruchaga, Carlos, Anso, Elena, Font, Maria, Martino, Virginia S, Rouzaut, Ana, and Martinez-irujo, Juan J

Biochem. J. 2007. 405(1): 165-171

3. 61118 HIV-LS-377; SCIFINDER-HIV-6/18/2007

Compounds and methods for inhibiting viral entry

Gervay-Hague, Jacquelyn, Meadows, Christopher D, North, Thomas W, and Duong, Yen T

PATENT: WO 2007065032 ISSUE DATE: 20070607

APPLICATION: 2006 PP: 61pp.

ASSIGNEE: (The Regents of the University of California, USA

4. 61119 HIV-LS-377; SCIFINDER-HIV-6/18/2007

Aminophenylsulfonamide derivatives as HIV protease inhibitors, their preparation, pharmaceutical compositions, and use in therapy

De Kock, Herman Augustinus, Jonckers, Tim Hugo Maria, Last, Stefaan Julien, Boonants, Paul Jozef Gabriel Maria, Surleraux, Dominique Louis Nestor Ghislain, and Wigerinck, Piet Tom Bert Paul

PATENT: WO 2007060253 ISSUE DATE: 20070531

APPLICATION: 2006 PP: 41pp.

ASSIGNEE: (Tibotec Pharmaceuticals Ltd., Ire.

5. 61120 HIV-LS-377; SCIFINDER-HIV-6/18/2007

Single-Stranded DNA Aptamer RT1t49 Inhibits RT Polymerase and RNase H Functions of HIV Type 1, HIV Type 2, and SIVCPZ RTs

Kissel, Jay D, Held, Daniel M, Hardy, Richard W, and Burke, Donald H

AIDS Res. Hum. Retroviruses 2007. 23(5): 699-708

6. 61121 HIV-LS-377; SCIFINDER-HIV-6/18/2007

Synthesis of novel 1,4-disubstituted nucleosides as potential antitumor agents

Kim, Aihong, Ko, Ok Hyun, and Hong, Joon Hee

Yakhak Hoechi 2007. 51(2): 103-107

7. 61122 HIV-LS-377; SCIFINDER-HIV-6/18/2007

MK-0518 HIV integrase inhibitor

Wang, Y, Serradell, N, Bolos, J, and Rosa, E

Drugs Future 2007. 32(2): 118-122

8. 61123 HIV-LS-377; SCIFINDER-HIV-6/18/2007

Sensitive and specific LC-ESI-MS/MS method for the determination of a styrylquinoline, BA011FZ041, a potent HIV anti-integrase agent, in rat plasma

Pruvost, Alain, Levi, Mikael, Zouhiri, Fatima, Menier, Isabelle, and Benech, Henri

J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007. 850(1-2): 259-266

9. 61124 HIV-LS-377; SCIFINDER-HIV-6/18/2007

Recombinant anti-viral polypeptides and conjugates of human interferon a for treating HCV, HBV and HIV infection

Paidhungat, Madan M, Sas, Ian, Bouquin, Thomas, Lin, David, Chen, Teddy, Guptill, Douglas, Brideau-Andersen, Amy, Bass, Steven H, and Patten, Phillip A

PATENT: WO 2007044083 ISSUE DATE: 20070419

APPLICATION: 2006 PP: 365pp.

ASSIGNEE: (Maxygen, Inc. USA

10. 61125 HIV-LS-377; SCIFINDER-HIV-6/18/2007

CD25+ Regulatory T Cells Isolated from HIV-Infected Individuals Suppress The Cytolytic And Nonlytic Antiviral Activity of HIV-specific CD8+ T Cells in Vitro

Kinter, Audrey L, Horak, Robin, Sion, Melanie, Riggin, Lindsey, McNally, Jonathan, Lin, Yin, Jackson, Robert, O'Shea, Angeline, Roby, Gregg, Kovacs, Colin, Connors, Mark, Migueles, Stephen A, and Fauci, Anthony S

AIDS Res. Hum. Retroviruses 2007. 23(3): 438-450

11. 61126 HIV-LS-377; SCIFINDER-HIV-6/18/2007

Preparation of alkenyldiarylmethanes and fused analogs as inhibitors of HIV-I reverse transcriptase

Cushman, Mark S and Deng, Bo-Liang

PATENT: WO 2007005531 ISSUE DATE: 20070111

APPLICATION: 2006 PP: 72pp.

ASSIGNEE: (Purdue Research Foundation, USA

12. 61127 HIV-LS-377; WOS-HI-6/22/2007

Interaction of Human Immunodeficiency Virus Type 1 Integrase With Cellular Nuclear Import Receptor Importin 7 and Its Impact on Viral Replication

Ao, Z. et al.

Journal of Biological Chemistry 2007. 282(18): 13456-13467


13. 61128 HIV-LS-377; WOS-HI-6/22/2007

Intensification of a Triple-Nucleoside Regimen With Tenofovir or Efavirenz in Hiv-1-Infected Patients With Virological Suppression

Gulick, R. et al.

Aids 2007. 21 (7): 813-823


14. 61129 HIV-LS-377; PUBMED-HIV-6/25/2007

Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases

Gagnon, A, Amad, MH, Bonneau, PR, Coulombe, R, Deroy, PL, Doyon, L, Duan, J, Garneau, M, Guse, I, Jakalian, A, Jolicoeur, E, Landry, S, Malenfant, E, Simoneau, B, and Yoakim, C

Bioorg Med Chem Lett 2007.


15. 61130 HIV-LS-377; PUBMED-HIV-6/25/2007

Synthesis and Anti-HIV Activity of New Metabolically Stable Alkenyldiarylmethane Non-Nucleoside Reverse Transcriptase Inhibitors Incorporating N-Methoxy Imidoyl Halide and 1,2,4-Oxadiazole Systems

Sakamoto, T, Cullen, MD, Hartman, TL, Watson, KM, Buckheit, RW, Pannecouque, C, Clercq, ED, and Cushman, M

J Med Chem 2007.


16. 61131 HIV-LS-377; PUBMED-HIV-6/25/2007

Design, synthesis, and antiviral evaluation of some 3'-carboxymethyl-3'-deoxyadenosine derivatives

Peterson, MA, Ke, P, Shi, H, Jones, C, McDougall, BR, and Robinson, WE Jr

Nucleosides Nucleotides Nucleic Acids 2007. 26(5): 499-519


17. 61132 HIV-LS-377; PUBMED-HIV-6/25/2007

Synthesis and Antiviral Evaluation of Azt Analogues with A Spacer Arm Between Glucidic and Base Moieties. Part II

Roy, V, Zerrouki, R, Krausz, P, Laumond, G, and Aubertin, AM

Nucleosides Nucleotides Nucleic Acids 2007. 26(5): 413-21


18. 61133 HIV-LS-377; PUBMED-HIV-6/25/2007

5'-Modified G-Quadruplex Forming Oligonucleotides Endowed with Anti-HIV Activity: Synthesis and Biophysical Properties

D'Onofrio, J, Petraccone, L, Erra, E, Martino, L, Fabio, GD, Napoli, LD, Giancola, C, and Montesarchio, D

Bioconjug Chem 2007.


19. 61134 HIV-LS-377; PUBMED-HIV-6/25/2007

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

Gulick, RM, Su, Z, Flexner, C, Hughes, MD, Skolnik, PR, Wilkin, TJ, Gross, R, Krambrink, A, Coakley, E, Greaves, WL, Zolopa, A, Reichman, R, Godfrey, C, Hirsch, M, and Kuritzkes, DR

J Infect Dis 2007. 196(2): 304-12


20. 61135 HIV-LS-377; PUBMED-HIV-6/25/2007

Anti HIV-1 Flavonoid Glycosides from Ochna integerrima

Reutrakul, V, Ningnuek, N, Pohmakotr, M, Yoosook, C, Napaswad, C, Kasisit, J, Santisuk, T, and Tuchinda, P

Planta Med 2007.


21. 61136 HIV-LS-377; PUBMED-HIV-6/25/2007

Synthetic access to spacer-linked 3,6-diamino-2,3,6-trideoxy-alpha-d-glucopyranosides-potential aminoglycoside mimics for the inhibition of the HIV-1 TAR-RNA/Tat-peptide complex

Joge, T, Jesberger, M, Broker, P, and Kirschning, A

Carbohydr Res 2007.


22. 61137 HIV-LS-377; PUBMED-HIV-6/25/2007

CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1

Heredia, A, Gilliam, B, Devico, A, Le, N, Bamba, D, Flinko, R, Lewis, G, Gallo, RC, and Redfield, RR

AIDS 2007. 21 (10): 1317-22


23. 61138 HIV-LS-377; PUBMED-HIV-6/25/2007

Design of Mutation-resistant HIV Protease Inhibitors with the Substrate Envelope Hypothesis

Chellappan, S, Kiran, Kumar Reddy GS, Ali, A, Nalam, MN, Anjum, SG, Cao, H, Kairys, V, Fernandes, MX, Altman, MD, Tidor, B, Rana, TM, Schiffer, CA, and Gilson, MK

Chem Biol Drug Des 2007. 69(5): 298-313


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024